ZNF683

gene
On this page

Also known as MGC33414Hobit

Summary

ZNF683 (zinc finger protein 683, HGNC:28495) is a protein-coding gene on chromosome 1p36.11, encoding Tissue-resident T-cell transcription regulator protein ZNF683 (Q8IZ20). Transcription factor that mediates a transcriptional program in various innate and adaptive immune tissue-resident lymphocyte T-cell types such as tissue-resident memory T (Trm), natural killer (trNK) and natural killer T (NKT) cells and negatively regulates gene expression of p….

Enables RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in T cell receptor signaling pathway; cellular response to ionomycin; and regulation of gene expression. Predicted to be located in nucleus.

Source: NCBI Gene 257101 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 94 total
  • MANE Select transcript: NM_001114759

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28495
Approved symbolZNF683
Namezinc finger protein 683
Location1p36.11
Locus typegene with protein product
StatusApproved
AliasesMGC33414, Hobit
Ensembl geneENSG00000176083
Ensembl biotypeprotein_coding
OMIM616775
Entrez257101

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 13 protein_coding

ENST00000349618, ENST00000403843, ENST00000416125, ENST00000423508, ENST00000436292, ENST00000451801, ENST00000453132, ENST00000454975, ENST00000455900, ENST00000897146, ENST00000897147, ENST00000897148, ENST00000897149

RefSeq mRNA: 3 — MANE Select: NM_001114759 NM_001114759, NM_001307925, NM_173574

CCDS: CCDS279, CCDS76126

Canonical transcript exons

ENST00000349618 — 6 exons

ExonStartEnd
ENSE000012309762636759326367797
ENSE000013372292636845826368585
ENSE000015496662636163426362022
ENSE000016725102636302626363154
ENSE000017433602636453226365226
ENSE000039015522637266926372750

Expression profiles

Bgee: expression breadth ubiquitous, 180 present calls, max score 94.37.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.0156 / max 197.0256, expressed in 97 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
111740.624681
111730.280343
111720.043217
111750.04263
111760.01653
2014190.00443
111770.00403

Top tissues by expression

221 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001994.37gold quality
left testisUBERON:000453394.33gold quality
right testisUBERON:000453494.09gold quality
granulocyteCL:000009493.09gold quality
testisUBERON:000047391.13gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.07gold quality
parotid glandUBERON:000183182.98silver quality
vena cavaUBERON:000408782.65gold quality
heart right ventricleUBERON:000208081.98silver quality
upper arm skinUBERON:000426381.86gold quality
left ventricle myocardiumUBERON:000656680.44gold quality
cardiac muscle of right atriumUBERON:000337980.39gold quality
pancreatic ductal cellCL:000207978.57silver quality
adult organismUBERON:000702378.38gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451178.01silver quality
trabecular bone tissueUBERON:000248377.90silver quality
body of tongueUBERON:001187677.24silver quality
lateral nuclear group of thalamusUBERON:000273677.02silver quality
ponsUBERON:000098876.37silver quality
lateral globus pallidusUBERON:000247676.30silver quality
epithelial cell of pancreasCL:000008376.15gold quality
cerebellar vermisUBERON:000472075.78silver quality
skeletal muscle tissue of biceps brachiiUBERON:000450275.44silver quality
layer of synovial tissueUBERON:000761674.62gold quality
substantia nigra pars reticulataUBERON:000196674.47silver quality
bloodUBERON:000017874.22gold quality
right uterine tubeUBERON:000130274.11gold quality
substantia nigra pars compactaUBERON:000196573.72silver quality
pylorusUBERON:000116673.69silver quality
cardia of stomachUBERON:000116273.30silver quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-8911yes591.56
E-ANND-3no2.18

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA2522.1ZNF683More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:39605320

Literature-anchored findings (GeneRIF, showing 7)

  • These data implicate Hobit as a novel transcriptional regulator in quiescent human effector-type CD8(+) T cells that regulates their immediate effector functions. (PMID:26179882)
  • Hobit’s function in human T cells is highly adapted to lifelong, periodic challenges with varying, physiological doses of pathogens. (PMID:26440905)
  • Transcription factor Hobit identifies a subset of NK cells in Human livers that express a distinct set of adhesion molecules and chemokine receptors consistent with tissue residency. These data suggest that Hobit is involved in regulating tissue-residency of human intrahepatic CD56bright NK cells in a subset of NK cells in inflamed livers. (PMID:28751776)
  • These findings suggest that Blimp-1 initiates cytotoxic effector function and that Hobit maintains cytotoxicity in a deployment-ready modus in tissue-resident memory CD8 T cells. (PMID:30051906)
  • Transcription Factor ZNF683 Inhibits SIV/HIV Replication through Regulating IFNgamma Secretion of CD8+ T Cells. (PMID:35458449)
  • Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. (PMID:36245253)
  • Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer. (PMID:36869093)

Cross-species orthologs

0 orthologs

Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)

Protein

Protein identifiers

Tissue-resident T-cell transcription regulator protein ZNF683Q8IZ20 (reviewed: Q8IZ20)

Alternative names: Homolog of Blimp-1 in T-cell, Zinc finger protein 683

All UniProt accessions (7): A0A0A0MSJ7, A0A0A0MT21, Q8IZ20, Q5T142, Q5T145, X1WI31, X1WI32

UniProt curated annotations — full annotation on UniProt →

Function. Transcription factor that mediates a transcriptional program in various innate and adaptive immune tissue-resident lymphocyte T-cell types such as tissue-resident memory T (Trm), natural killer (trNK) and natural killer T (NKT) cells and negatively regulates gene expression of proteins that promote the egress of tissue-resident T-cell populations from non-lymphoid organs. Plays a role in the development, retention and long-term establishment of adaptive and innate tissue-resident lymphocyte T cell types in non-lymphoid organs, such as the skin and gut, but also in other nonbarrier tissues like liver and kidney, and therefore may provide immediate immunological protection against reactivating infections or viral reinfection. Also plays a role in the differentiation of both thymic and peripheral NKT cells. Negatively regulates the accumulation of interferon-gamma (IFN-gamma) in NKT cells at steady state or after antigenic stimulation. Positively regulates granzyme B production in NKT cells after innate stimulation. Associates with the transcriptional repressor PRDM1/BLIMP1 to chromatin at gene promoter regions. Lacks transcriptional repressor activity. Binds to DNA within promoter regions of the transcriptional repressor PRDM1/BLIMP1 target sites. Unable to regulate interferon-gamma (IFN-gamma) production in cytomegalovirus (CMV)-infected effector CD8(+) T-cells. Transcriptional repressor that binds to DNA within promoter regions of the transcriptional repressor PRDM1/BLIMP1 target sites. Regulates interferon-gamma (IFN-gamma) production in cytomegalovirus (CMV)-infected effector CD8(+) T cells.

Subcellular location. Nucleus.

Tissue specificity. Expressed in terminally differentiated effector CD8(+) T-cells, but not in naive and central memory cells. Expressed in terminally differentiated natural killer (NK) cells and natural killer (NKT) T-cells (at protein level). Expressed strongly in effector-type CD8(+) T-cells and weakly in naive and memory CD8(+) T-cells. Expressed in terminally differentiated natural killer (NK) cells. Isoform 2 is strongly expressed in effector CD8(+) T and natural killer (NK) cells. Isoform 1 is expressed in effector CD8(+) T and natural killer (NK) cells. (Microbial infection) Expressed in cytomegalovirus (CMV)-infected effector CD8(+) T-cells (at protein level).

Domain organisation. The C2H2-type zinc finger are necessary for DNA-binding.

Induction. (Microbial infection) Up-regulated by cytomegalovirus (CMV) infection in long-lived effector CD8(+) T-cells.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8IZ20-11, Extra large, XLyes
Q8IZ20-22, Large, L

RefSeq proteins (3): NP_001108231, NP_001294854, NP_775845 (=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050331Zinc_finger_PRDM4/PRDM1/PRDM14Family

Pfam: PF00096

UniProt features (14 total): sequence variant 5, zinc finger region 4, region of interest 2, chain 1, compositionally biased region 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IZ20-F150.040.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 96 (showing top): GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE, GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_REGULATION_OF_HEMOPOIESIS, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION, GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION

GO Biological Process (16): negative regulation of transcription by RNA polymerase II (GO:0000122), adaptive immune response (GO:0002250), regulation of transcription by RNA polymerase II (GO:0006357), regulation of gene expression (GO:0010468), positive regulation of gene expression (GO:0010628), negative regulation of type II interferon production (GO:0032689), regulation of natural killer cell differentiation (GO:0032823), obsolete regulation of natural killer cell differentiation involved in immune response (GO:0032826), regulation of extrathymic T cell differentiation (GO:0033082), innate immune response (GO:0045087), T cell receptor signaling pathway (GO:0050852), regulation of NK T cell differentiation (GO:0051136), cellular response to ionomycin (GO:1904637), immune system process (GO:0002376), regulation of immune system process (GO:0002682), regulation of multicellular organismal process (GO:0051239)

GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), promoter-specific chromatin binding (GO:1990841), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transcription by RNA polymerase II2
immune response2
regulation of DNA-templated transcription2
gene expression2
regulation of biological process2
regulation of transcription by RNA polymerase II1
negative regulation of DNA-templated transcription1
regulation of macromolecule biosynthetic process1
regulation of gene expression1
positive regulation of macromolecule biosynthetic process1
negative regulation of cytokine production1
type II interferon production1
regulation of type II interferon production1
natural killer cell differentiation1
regulation of natural killer cell activation1
regulation of lymphocyte differentiation1
extrathymic T cell differentiation1
regulation of T cell differentiation1
defense response to symbiont1
antigen receptor-mediated signaling pathway1
NK T cell differentiation1
regulation of alpha-beta T cell differentiation1
cellular response to ether1
cellular response to fatty acid1
response to ionomycin1
biological_process1
immune system process1
multicellular organismal process1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
cis-regulatory region sequence-specific DNA binding1
transcription cis-regulatory region binding1
transcription regulator activity1
transition metal ion binding1
chromatin binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

568 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF683EOMESO95936608
ZNF683ITGAEP38570607
ZNF683ITGA1P56199606
ZNF683RUNX3Q13761595
ZNF683S1PR1P21453592
ZNF683TBX21Q9UL17580
ZNF683CD69Q07108577
ZNF683KLRD1Q13241554
ZNF683CXCR6O00574546
ZNF683KLRK1P26718524
ZNF683GZMKP49863513
ZNF683PRDM1O75626512
ZNF683CCR7P32248507
ZNF683CD8AP01732507
ZNF683CRTAMO95727490

IntAct

16 interactions, top by confidence:

ABTypeScore
CYSRT1ZNF683psi-mi:“MI:0915”(physical association)0.560
ZNF683ZNF330psi-mi:“MI:0915”(physical association)0.560
PRR20DZNF683psi-mi:“MI:0915”(physical association)0.560
ZNF683RHOXF2psi-mi:“MI:0915”(physical association)0.560
KRTAP6-2ZNF683psi-mi:“MI:0915”(physical association)0.560
ZNF683CYSRT1psi-mi:“MI:0915”(physical association)0.000
ZNF330ZNF683psi-mi:“MI:0915”(physical association)0.000
PRR20DZNF683psi-mi:“MI:0915”(physical association)0.000
RHOXF2ZNF683psi-mi:“MI:0915”(physical association)0.000
ZNF683KRTAP6-2psi-mi:“MI:0915”(physical association)0.000

BioGRID (9): ZNF683 (Two-hybrid), ZNF683 (Two-hybrid), KRTAP6-2 (Two-hybrid), CYSRT1 (Two-hybrid), PRR20B (Two-hybrid), PRR20A (Two-hybrid), PRR20D (Two-hybrid), PRR20C (Two-hybrid), PRR20E (Two-hybrid)

ESM2 similar proteins: A0A5F9ZHS7, A1YGK1, A2T7E6, A8MZG2, O08574, O43593, O60393, O75593, O88621, O95231, P0C1T1, P0CG20, P20428, P97609, Q04667, Q17QR5, Q2KIS6, Q2M1V0, Q2T9Q7, Q32LE6, Q497V6, Q5JUK2, Q5M844, Q5RJB0, Q5TGS1, Q61645, Q61657, Q6ZMY3, Q6ZN32, Q6ZNG2, Q7RTU1, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8N1L9, Q8N7G0, Q8N944, Q8N9Y4

Diamond homologs: I7HJS4, O75626, Q60636, Q8IZ20, Q93560, A0A163UT06, A2AGX3, A2AJ77, A2BID7, A6QPM3, B4F6U4, E9Q3T6, E9Q8T2, P0C6Y7, P57071, Q13029, Q3UTQ7, Q3UZD5, Q5R5M1, Q5RAX9, Q63755, Q80V63, Q96EQ9, Q9CXE0, Q9GZV8, Q9H4Q4, Q9NQV5, Q9NQV6, Q9NQV7, Q9NQW5, Q9NQX0, Q9NQX1, Q9QZP2, Q9UKN5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

94 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance79
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1368 predictions. Top by Δscore:

VariantEffectΔscore
1:26367591:A:ACdonor_gain1.0000
1:26367592:C:CCdonor_gain1.0000
1:26367592:CT:Cdonor_gain1.0000
1:26362020:CAC:Cacceptor_gain0.9900
1:26362021:ACC:Aacceptor_loss0.9900
1:26362022:CCT:Cacceptor_loss0.9900
1:26362023:CTGA:Cacceptor_loss0.9900
1:26362024:T:Gacceptor_loss0.9900
1:26365115:C:CAdonor_gain0.9900
1:26372667:A:ACdonor_gain0.9900
1:26372668:C:CCdonor_gain0.9900
1:26372668:CT:Cdonor_gain0.9900
1:26372687:T:Adonor_gain0.9900
1:26362018:CACAC:Cacceptor_gain0.9800
1:26363019:ATCTC:Adonor_loss0.9800
1:26363020:TCTCA:Tdonor_loss0.9800
1:26363021:CTCA:Cdonor_loss0.9800
1:26363022:TCACC:Tdonor_loss0.9800
1:26363023:CACCG:Cdonor_loss0.9800
1:26363024:A:Tdonor_loss0.9800
1:26364527:GATA:Gdonor_loss0.9800
1:26364528:ATAC:Adonor_loss0.9800
1:26364529:TA:Tdonor_loss0.9800
1:26364530:ACC:Adonor_loss0.9800
1:26364531:C:CAdonor_loss0.9800
1:26364562:G:Adonor_gain0.9800
1:26365054:T:Adonor_gain0.9800
1:26365120:G:Adonor_gain0.9800
1:26365146:G:Cdonor_gain0.9800
1:26365151:T:TAdonor_gain0.9800

AlphaMissense

3280 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:26362005:G:CF407L0.999
1:26362005:G:TF407L0.999
1:26362007:A:GF407L0.999
1:26363075:A:GL365P0.999
1:26363092:G:CF359L0.999
1:26363092:G:TF359L0.999
1:26363094:A:GF359L0.999
1:26364553:A:CF331L0.999
1:26364553:A:TF331L0.999
1:26364555:A:GF331L0.999
1:26364576:A:GC324R0.999
1:26361921:G:CF435L0.998
1:26361921:G:TF435L0.998
1:26361923:A:GF435L0.998
1:26362006:A:GF407S0.998
1:26363067:G:CH368D0.998
1:26363093:A:GF359S0.998
1:26363104:G:CC355W0.998
1:26363106:A:GC355R0.998
1:26363115:A:GC352R0.998
1:26363119:G:CF350L0.998
1:26363119:G:TF350L0.998
1:26363121:A:GF350L0.998
1:26363147:A:GL341P0.998
1:26364536:A:GL337P0.998
1:26364565:A:CC327W0.998
1:26364566:C:GC327S0.998
1:26364566:C:TC327Y0.998
1:26364567:A:GC327R0.998
1:26364567:A:TC327S0.998

dbSNP variants (sampled 300 via entrez): RS1000083207 (1:26373586 C>G), RS1000148673 (1:26361615 C>T), RS1000178584 (1:26366271 G>A), RS1000357740 (1:26372420 A>G), RS1000834320 (1:26371959 C>T), RS1000992854 (1:26361170 C>A), RS1001145081 (1:26366800 C>T), RS1001252855 (1:26364467 G>C), RS1001435913 (1:26370570 C>G), RS1001643707 (1:26371004 C>T), RS1001867751 (1:26363685 T>C), RS1001926782 (1:26370032 G>A), RS1002082844 (1:26375464 C>A), RS1002719579 (1:26363533 C>T), RS1003157382 (1:26363922 T>A,C)

Disease associations

OMIM: gene MIM:616775 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsdecreases expression, increases abundance, increases expression2
Benzo(a)pyreneaffects methylation, increases mutagenesis2
GSK-J4decreases expression1
butylbenzyl phthalateincreases expression1
di-n-butylphosphoric acidaffects expression1
Amiodaroneincreases expression1
Testosteronedecreases expression1
Valproic Acidincreases methylation1
Antirheumatic Agentsdecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.